Clinical Trials Browser

Phase 1/2 × Withdrawn × dabrafenib × Clear all

NCT02143050 2023-11-18

Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients

Phase 1/2 Withdrawn

Melanoma